Home / About / Publications / Oncology Issues Journal

Oncology Issues Journal

Oncology Issues is the official journal of the Association of Cancer Care Centers (ACCC). As one of the only non-clinical, programmatic journals covering cancer, Oncology Issues provides “how-to” articles for the entire multidisciplinary oncology care team, on a wide range of topics.

How One Community Exercise Program for People Living With Cancer Impacted Health Care Utilization

By Hanna Grossman, Margot J. Burnell, and Danielle R. Bouchard

Learn about the transformative benefits of the Stay Strong program, a free 12-week exercise program designed for cancer survivors. Participants experienced reduced hospital admissions, shorter hospital stays, and improved quality of life, highlighting the long-term benefits of integrating exercise into cancer care.
Read Full Article

Also In This Issue:

5 Steps to Building a Cancer Center Community Advisory Board
Read how this board fosters meaningful engagement with diverse patient populations, amplifies community health initiatives, and supports the University of Vermont Cancer Center’s mission.
Implementation of a Lung Cancer Screening Program in a Community Setting
Lung cancer remains the leading cause of cancer deaths in the U.S., yet only a small percentage of high-risk individuals are screened. Learn how the Providence Holy Cross Medical Center’s lung cancer screening program significantly improves patient outcomes, and understand the importance of increased patient and provider education.
Citrus Oncology: An Interview with Aabid and Afreen Shariff
Dive into Citrus Oncology’s virtual clinic, which provides rapid access to specialists who manage treatment-related side effects and organ toxicities from cancer treatment, improving patient outcomes and quality of life.
Technology-Enabled Assessments Support Remote Care of Oncology Patients and Improve the Care Team Experience
This pilot feasibility study demonstrated that remote patient monitoring and electronic patient-reported outcomes can improve the management of febrile neutropenia in oncology patients.
[Sponsored Content] The Power of Serial Measurable Residual Disease Assessment to Inform Treatment Decisions in Colorectal Cancer
Circulating tumor DNA is revolutionizing cancer diagnostics by enabling the detection of molecular residual disease in blood. Natera’s Signatera test offers highly sensitive, personalized monitoring of tumor DNA, aiding in early detection and treatment planning.